Skip to main content

Tenet Diagnostics, MedTek21 Ink Medication Monitoring Software Deal

NEW YORK (GenomeWeb) – Laboratory testing firm Tenet Diagnostics announced today that it has signed an agreement to use MedTek21's medication risk management platform with its pharmacogenetic test services.

MedTek21's software platform is designed to continuously analyze patient records to provide real-time personalized medication reports that can help physicians identify potential medication risks. It is designed to work on desktop computers, tablets, and mobile devices.

Specific terms of the deal were not disclosed.

"By avoiding [adverse drug events], identifying responders and non-responders to medications, and optimizing drug dosage, Tenet PGx testing helps to improve individual patient outcomes while lowering the overall cost of care for health payers," Tenet CMO Scott Howell said in a statement.